NDC00093-4175-73: CEPHALEXIN FOR ORAL SUSPENSION.
The CEPHALEXIN FOR ORAL SUSPENSION is a the manufacturer industrial component. Key specifications include flavor: PALATABLE, physical_form: POWDER, administration: ORAL, primary_container_type: BOTTLE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 2.500 UNITS OF ACTIVE INGREDIENT. This part is cataloged in the U.S.
Government catalog under NSN 6505-00-009-1833, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| flavor | PALATABLE |
| physical_form | POWDER |
| administration | ORAL |
| special_features | BOTTLE W/CHILD-PROOF SAFETY CLOSURE OF SUFFICIENT CAPACITY TO HOLD 100 ML W/ADEQUATE SHAKE SPACE; EQUIVALENT TO 125 MG CEPHALEXIN PER 5 ML WHEN RECONSTITUTED TO 100 ML |
| primary_container_type | BOTTLE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 2.500 UNITS OF ACTIVE INGREDIENT |
| active_medicament_medicinal_strength | 2.500 GRAMS CEPHALEXIN EQUIVALENT G |
| part_name_assigned_by_controlling_agency | CEPHALEXIN FOR ORAL SUSPENSION USP 125 MG PER 5ML 100ML |
| NSN | 6505-00-009-1833 |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 2.500 UNITS OF ACTIVE INGREDIENT |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| FLAVOR | PALATABLE |
| PRIMARY CONTAINER TYPE | BOTTLE |
| PHYSICAL FORM | POWDER |
| SPECIAL FEATURES | BOTTLE W/CHILD-PROOF SAFETY CLOSURE OF SUFFICIENT CAPACITY TO HOLD 100 ML W/ADEQUATE SHAKE SPACE; EQUIVALENT TO 125 MG CEPHALEXIN PER 5 ML WHEN RECONSTITUTED TO 100 ML |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CEPHALEXIN FOR ORAL SUSPENSION USP 125 MG PER 5ML 100ML |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 2.500 GRAMS CEPHALEXIN EQUIVALENT G |
No substitute or cross-reference records for this part.